anti-SARS-CoV-2 vaccine (CEL-SCI)

N/A

Report date: 2025/01/26 17:59:41

Base Information

Drug Nameanti-SARS-CoV-2 vaccine (CEL-SCI)

Drug Alias NameCOV-19 peptides LEAPS (CEL-SCI)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCel-Sci Corp

China Registration ClassN/A

Develop Information

Active CompaniesCel-Sci Corp

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A